Dr. Ashleys Labs Profile
Key Indicators
- Authorised Capital ₹ 3.50 Cr
as on 18-07-2024
- Paid Up Capital ₹ 3.17 Cr
as on 18-07-2024
- Company Age 46 Year, 30 Days
- Last Filing with ROC 30 Sep 2011
- Open Charges ₹ 200.29 Cr
as on 18-07-2024
- Satisfied Charges ₹ 136.36 Cr
as on 18-07-2024
About Dr. Ashleys Labs
The Corporate was formerly known as Dr. Ashleys Labs Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 30 September 2011. It's a company limited by shares with an authorized capital of Rs 3.50 Cr and a paid-up capital of Rs 3.17 Cr.
The company currently has active open charges totaling ₹200.29 Cr. The company has closed loans amounting to ₹136.36 Cr, as per Ministry of Corporate Affairs (MCA) records.
Gopinathan Mudavinammannil, Nagesh Naik, and Satish Patil serve as directors at the Company.
- CIN/LLPIN
U24234MH1978PLC020792
- Company No.
020792
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
25 Nov 1978
- Date of AGM
30 Sep 2011
- Date of Balance Sheet
30 Sep 2011
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Navi Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Dr. Ashleys Labs?
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Gopinathan Mudavinammannil | Additional Director | 01-Mar-2016 | Current |
Nagesh Naik | Additional Director | Current | |
Satish Patil | Additional Director | Current |
Financial Performance of Dr. Ashleys Labs.
Enhance accessibility to Dr. Ashleys Labs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
What is the Ownership and Shareholding Structure of Dr. Ashleys Labs?
Unlock access to Dr. Ashleys Labs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Bank Of Baroda Creation Date: 23 Mar 2012 | ₹200.29 Cr | Open |
State Bank Of India With The Shamrao Vithal Co-Op. Bank Ltd. And Corporation Bank And Idbi Bank Ltd. Creation Date: 25 Feb 2011 | ₹115.07 Cr | Satisfied |
Axis Bank Limited Creation Date: 29 Sep 2009 | ₹6.90 Cr | Satisfied |
How Many Employees Work at Dr. Ashleys Labs?
Unlock and access historical data on people associated with Dr. Ashleys Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr. Ashleys Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr. Ashleys Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.